184 related articles for article (PubMed ID: 30924090)
21. Embryonic stem cells or induced pluripotent stem cells? A DNA integrity perspective.
Bai Q; Desprat R; Klein B; Lemaître JM; De Vos J
Curr Gene Ther; 2013 Apr; 13(2):93-8. PubMed ID: 23317057
[TBL] [Abstract][Full Text] [Related]
22. Induced pluripotent stem cells (iPSCs)--a new era of reprogramming.
Kang L; Kou Z; Zhang Y; Gao S
J Genet Genomics; 2010 Jul; 37(7):415-21. PubMed ID: 20659705
[TBL] [Abstract][Full Text] [Related]
23. Pluripotent Stem Cell-Based Cell Therapy-Promise and Challenges.
Yamanaka S
Cell Stem Cell; 2020 Oct; 27(4):523-531. PubMed ID: 33007237
[TBL] [Abstract][Full Text] [Related]
24. SARS-CoV-2 research using human pluripotent stem cells and organoids.
Deguchi S; Serrano-Aroca Á; Tambuwala MM; Uhal BD; Brufsky AM; Takayama K
Stem Cells Transl Med; 2021 Nov; 10(11):1491-1499. PubMed ID: 34302450
[TBL] [Abstract][Full Text] [Related]
25. Inducible pluripotent stem cells: not quite ready for prime time?
Robbins RD; Prasain N; Maier BF; Yoder MC; Mirmira RG
Curr Opin Organ Transplant; 2010 Feb; 15(1):61-7. PubMed ID: 19855280
[TBL] [Abstract][Full Text] [Related]
26. Cell-based interventions for neurologic conditions: ethical challenges for early human trials.
Mathews DJ; Sugarman J; Bok H; Blass DM; Coyle JT; Duggan P; Finkel J; Greely HT; Hillis A; Hoke A; Johnson R; Johnston M; Kahn J; Kerr D; Kurtzberg J; Liao SM; McDonald JW; McKhann G; Nelson KB; Rao M; Regenberg A; Siegel AW; Smith K; Solter D; Song H; Vescovi A; Young W; Gearhart JD; Faden R
Neurology; 2008 Jul; 71(4):288-93. PubMed ID: 18463365
[TBL] [Abstract][Full Text] [Related]
27. New Immunosuppressive Cell Therapy to Prolong Survival of Induced Pluripotent Stem Cell-Derived Allografts.
Sasaki H; Wada H; Baghdadi M; Tsuji H; Otsuka R; Morita K; Shinohara N; Seino K
Transplantation; 2015 Nov; 99(11):2301-10. PubMed ID: 26360665
[TBL] [Abstract][Full Text] [Related]
28. iPS cell technologies and cartilage regeneration.
Tsumaki N; Okada M; Yamashita A
Bone; 2015 Jan; 70():48-54. PubMed ID: 25026496
[TBL] [Abstract][Full Text] [Related]
29. Cell-based interventions for neurologic conditions: ethical challenges for early human trials.
Pullicino PM; Burke WJ
Neurology; 2009 May; 72(19):1709; author reply 1709. PubMed ID: 19433751
[No Abstract] [Full Text] [Related]
30. Human artificial chromosomes for pluripotent stem cell-based tissue replacement therapy.
Sinenko SA; Ponomartsev SV; Tomilin AN
Exp Cell Res; 2020 Apr; 389(1):111882. PubMed ID: 32017931
[TBL] [Abstract][Full Text] [Related]
31. Application of induced pluripotent stem cell transplants: Autologous or allogeneic?
Li C; Chen S; Zhou Y; Zhao Y; Liu P; Cai J
Life Sci; 2018 Nov; 212():145-149. PubMed ID: 30290185
[TBL] [Abstract][Full Text] [Related]
32. Steps toward safe cell therapy using induced pluripotent stem cells.
Okano H; Nakamura M; Yoshida K; Okada Y; Tsuji O; Nori S; Ikeda E; Yamanaka S; Miura K
Circ Res; 2013 Feb; 112(3):523-33. PubMed ID: 23371901
[TBL] [Abstract][Full Text] [Related]
33. Neural crest stem cells and their potential therapeutic applications.
Liu JA; Cheung M
Dev Biol; 2016 Nov; 419(2):199-216. PubMed ID: 27640086
[TBL] [Abstract][Full Text] [Related]
34. Generation of clinically relevant "induced pluripotent stem" (iPS) cells.
Heffernan C; Sumer H; Verma PJ
J Stem Cells; 2011; 6(3):109-27. PubMed ID: 23264997
[TBL] [Abstract][Full Text] [Related]
35. The bioethics of stem cell research and therapy.
Hyun I
J Clin Invest; 2010 Jan; 120(1):71-5. PubMed ID: 20051638
[TBL] [Abstract][Full Text] [Related]
36. Induced pluripotent stem cells in regenerative medicine and disease modeling.
Walmsley GG; Hyun J; McArdle A; Senarath-Yapa K; Hu MS; Chung MT; Wong VW; Longaker MT; Wan DC
Curr Stem Cell Res Ther; 2014 Mar; 9(2):73-81. PubMed ID: 24359141
[TBL] [Abstract][Full Text] [Related]
37. From skin to the treatment of diseases--the possibilities of iPS cell research in dermatology.
Galach M; Utikal J
Exp Dermatol; 2011 Jun; 20(6):523-8. PubMed ID: 21585557
[TBL] [Abstract][Full Text] [Related]
38. Concise review: Immune recognition of induced pluripotent stem cells.
Boyd AS; Rodrigues NP; Lui KO; Fu X; Xu Y
Stem Cells; 2012 May; 30(5):797-803. PubMed ID: 22419544
[TBL] [Abstract][Full Text] [Related]
39. Current status of treating neurodegenerative disease with induced pluripotent stem cells.
Pen AE; Jensen UB
Acta Neurol Scand; 2017 Jan; 135(1):57-72. PubMed ID: 26748435
[TBL] [Abstract][Full Text] [Related]
40. Ten years of induced pluripotency: from basic mechanisms to therapeutic applications.
Karagiannis P; Eto K
Development; 2016 Jun; 143(12):2039-43. PubMed ID: 27302394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
